Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03174197
What this trial is testing

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 60
Not applicableWithdrawnNCT00005790
What this trial is testing

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Testing effectiveness (Phase 2)Study completedNCT01402063
What this trial is testing

PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation

Who this might be right for
Glioblastoma Multiforme
Brown University 63
Early research (Phase 1)Ended earlyNCT01702792
What this trial is testing

Derivation of Tumor Specific Hybridomas

Who this might be right for
Glioblastoma
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Ended earlyNCT05074992
What this trial is testing

A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University College, London 1
Early research (Phase 1)Study completedNCT02270034
What this trial is testing

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme (Grade IV) of Cerebellum
Grupo Español de Investigación en Neurooncología 38
Testing effectiveness (Phase 2)WithdrawnNCT03506139
What this trial is testing

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
John M. Buatti
Testing effectiveness (Phase 2)UnknownNCT06186440
What this trial is testing

Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Zhongnan Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00200161
What this trial is testing

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Who this might be right for
GlioblastomaGliomas
Memorial Sloan Kettering Cancer Center 127
Testing effectiveness (Phase 2)Ended earlyNCT00376103
What this trial is testing

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Methodist Healthcare - Memphis 3
Testing effectiveness (Phase 2)Study completedNCT00006388
What this trial is testing

Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 77
Testing effectiveness (Phase 2)Study completedNCT00879437
What this trial is testing

Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Glial Cell TumorsMalignant GliomasGlioblastoma Multiforme+5 more
Baylor College of Medicine 38
Not applicableUnknownNCT04717739
What this trial is testing

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Who this might be right for
Glioblastoma
NovoCure Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Early research (Phase 1)Study completedNCT00977431
What this trial is testing

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Who this might be right for
Glioblastoma
Boehringer Ingelheim 36
Early research (Phase 1)Not Yet RecruitingNCT06524063
What this trial is testing

Targeted Survivin DC Cell Injection for the Treatment of GBM

Who this might be right for
Glioblastoma
Beijing Tricision Biotherapeutics Inc 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07439172
What this trial is testing

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Who this might be right for
High Grade GliomasGlioblastomaAstrocytoma+1 more
The Cooper Health System 70
Testing effectiveness (Phase 2)Ended earlyNCT00238277
What this trial is testing

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Next Page